Asian Phytoceuticals Public Company vs Procter & Gamble: Fair Value & Quality
Both stocks run through our valuation models. Here is how Asian Phytoceuticals Public Company (APCO) and Procter & Gamble (PG) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees Procter & Gamble as the less overvalued of the two: Asian Phytoceuticals Public Company trades at THB 2.56 versus a fair value of THB 1.42 (-45%), while Procter & Gamble trades at $146 versus $108 (-26%).
Asian Phytoceuticals Public Company
APCO.BK · THB · Consumer Staples
-45%
upside to fair value
overvalued
PriceTHB 2.56
Fair ValueTHB 1.42
Quality76/100
Procter & Gamble
PG · USD · Consumer Staples
-26%
upside to fair value
overvalued
Price$146
Fair Value$108
Quality75/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Asian Phytoceuticals Public CompanyProcter & Gamble
Valuation
26.2×P/E (TTM)21.5×
7.79×P/S (TTM)3.95×
2.82×P/B6.58×
22.7×EV/EBITDA14.3×
—PEG4.13×
3.5%Dividend yield2.9%
THB 0.09Dividend per share$4.23
Profitability
30%Net margin19%
29%Operating margin23%
11%Return on equity31%
6%Return on assets11%
Growth
4%Revenue growth (YoY)7%
-7.2%Avg. growth/yr (3Y)1.7%
-4.2%Avg. growth/yr (5Y)3.5%
Balance & size
0.00×Debt / equity0.48×
$47MMarket cap$342B
weakGrowth qualityhealthy
Procter & Gamble leads: 5 to 8 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Asian Phytoceuticals Public Companyof which business quality 74 · market factors 45Procter & Gambleof which business quality 71 · market factors 54
ProfitabilityMargins and returns on capital today
53
73
Quality GrowthAre margins and returns improving?
37
46
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
100
85
Low VolatilityCalm price path (market factor)
96
95
MomentumPrice trend over the last 3–12 months (market factor)
30
40
52W MomentumDistance to the 52-week high (market factor)
12
33
Net IssuanceBuybacks instead of dilution
82
91
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Asian Phytoceuticals Public Company
DCF ModelsTHB 1.37
Earnings-BasedTHB 0.78
Dividend DiscountTHB 0.81
MultiplesTHB 1.63
Asset-BasedTHB 0.62
Growth DCFTHB 1.06
Economic ProfitTHB 0.81
Growth EarningsTHB 1.47
24 of 24 models see the stock below the current price.
Procter & Gamble
DCF Models$97.73
Earnings-Based$85.21
Dividend Discount$59.55
Multiples$120
Asset-Based$14.97
Growth DCF$74.21
Economic Profit$68.20
Growth Earnings$112
24 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Asian Phytoceuticals Public Company
Bear THB 1.11Fair Value THB 1.42Bull THB 1.98
THB 2.56 = current price (white tick)
Procter & Gamble
Bear $70.77Fair Value $108Bull $151
$146 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Asian Phytoceuticals Public Company · Consumer Staples
Quality score76 · Top 25%
Fair value upside-45% · bottom 25%
Procter & Gamble · Consumer Staples
Quality score75 · Top 25%
Fair value upside-26% · below median
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees Procter & Gamble as the less overvalued of the two: Asian Phytoceuticals Public Company trades at THB 2.56 versus a fair value of THB 1.42 (-45%), while Procter & Gamble trades at $146 versus $108 (-26%).
Asian Phytoceuticals Public Company has the higher quality score (76/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
